ConductScience.org, home

Paper33658348

T cell epitope screening of Epstein-Barr virus fusion protein gB.

Chen H and 16 others. J Virol, 2021. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. T cell epitope screening of Epstein-Barr virus fusion protein gB. Papers, record 33658348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33658348

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
T cell epitope screening of Epstein-Barr virus fusion protein gB.
PubMed
Journal
J Virol
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.5
iCite
Revised in PubMed
2023-02-28
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen HHaiwen
2Zhang XXiao
3Zhang SShanshan
4Duan XXiaobing
5Xiang TTong
6Zhou XXiang
7Zhang WWanlin
8Zhang XXinyu
9Feng QQisheng
10Kang YYinfeng
11Li JJiangping
12Deng LLan
13Wang LLiang
14Lv XXing
15Zeng MMusheng
16Zeng YXYi-Xin
17Xu MMiao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111018123Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases.Annu Rev Microbiol2000https://conductscience.org/library/papers/11018123PubMed
224146041CD8+ T cell responses to lytic EBV infection: late antigen specificities as subdominant components of the total response.J Immunol2013https://conductscience.org/library/papers/24146041PubMed
315744535The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage.Immunogenetics2005https://conductscience.org/library/papers/15744535PubMed
423867012Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.Vaccine2014https://conductscience.org/library/papers/23867012PubMed
526969667Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing.Front Med2016https://conductscience.org/library/papers/26969667PubMed
614662920Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers.J Clin Microbiol2003https://conductscience.org/library/papers/14662920PubMed
731209392Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma.Nat Genet2019https://conductscience.org/library/papers/31209392PubMed
830714987Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.J Clin Invest2019https://conductscience.org/library/papers/30714987PubMed
928296763
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol.
Medicine (Baltimore)2017https://conductscience.org/library/papers/28296763PubMed
1017360652Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17360652PubMed
1123601786Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma.Virology2013https://conductscience.org/library/papers/23601786PubMed
1221123379
The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways.
J Virol2011https://conductscience.org/library/papers/21123379PubMed
131334711Epstein-Barr virus BCRF1 gene product (viral interleukin 10) inhibits superoxide anion production by human monocytes.Lymphokine Cytokine Res1992https://conductscience.org/library/papers/1334711PubMed
1423209447The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.PLoS Genet2012https://conductscience.org/library/papers/23209447PubMed
1517846036Clustal W and Clustal X version 2.0.Bioinformatics2007https://conductscience.org/library/papers/17846036PubMed
1616549597Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.J Exp Med2006https://conductscience.org/library/papers/16549597PubMed
1729292383Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.Nat Microbiol2018https://conductscience.org/library/papers/29292383PubMed
1819647480Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant.J Clin Virol2009https://conductscience.org/library/papers/19647480PubMed
1927198675Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.Science2016https://conductscience.org/library/papers/27198675PubMed
2030248160Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection.PLoS Pathog2018https://conductscience.org/library/papers/30248160PubMed

See all 51 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
39346922Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice.Front Immunol2024https://conductscience.org/library/papers/39346922PubMed
38906867A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection.Nat Commun2024https://conductscience.org/library/papers/38906867PubMed
38793551Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics.Viruses2024https://conductscience.org/library/papers/38793551PubMed
36713430Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma.Front Immunol2022https://conductscience.org/library/papers/36713430PubMed
35404082Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses.J Virol2022https://conductscience.org/library/papers/35404082PubMed
34834989Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) Doses.Viruses2021https://conductscience.org/library/papers/34834989PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33658348

GET https://conductscience.org/api/papers/v1/33658348/references?page=2